Samsung Biologics, Foreign Investors Net Sell 3,150 Shares... Stock Price Down 0.29%
Samsung Biologics has newly appeared among the top searched stocks.
As of 2:31 PM on the 10th, Samsung Biologics is trading at 689,000 KRW, up 0.29% from the previous day. This is a 15.15% decrease compared to February 5. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have net sold 3,150 shares of Samsung Biologics, while institutions have net bought 2,000 shares, according to provisional data. Over the past five days, individual investors have net bought 106,371 shares, whereas foreigners and institutions have net sold 76,779 shares and 32,039 shares respectively.
Hot Picks Today
"Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.